Actively Recruiting

Phase Not Applicable
Age: 16Years +
All Genders
NCT02292641

Beyond TME Origins

Led by Imperial College London · Updated on 2024-10-17

383

Participants Needed

4

Research Sites

896 weeks

Total Duration

On this page

Sponsors

I

Imperial College London

Lead Sponsor

P

Pelican Cancer Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

All patients with recurrent colorectal cancer in the pelvis are eligible. The original primary tumour staging scans and resected surgical specimen needs to be available. Patients' recurrence will be staged using our proposed MRI classification. We will be assessing the original primary staging scans and histopathology to learn about risk factors for recurrence. We will record treatment for the recurrence, and patients will be followed up for three years.

CONDITIONS

Official Title

Beyond TME Origins

Who Can Participate

Age: 16Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Had a primary colorectal adenocarcinoma proven by biopsy taken as part of routine clinical practice
  • Has a confirmed diagnosis of recurrent pelvic colorectal cancer
  • Has previously completed surgical treatment of primary adenocarcinoma of the colon, sigmoid colon or rectum
  • Are able to undergo high resolution MRI for staging prior to treatment decisions
  • Have provided written informed consent to participate in the study
  • Be aged 16 years or over
Not Eligible

You will not qualify if you...

  • Have irresectable extra-pelvic metastatic disease
  • Original baseline staging and preoperative restaging scans (MR for rectal and sigmoid cancers and/or CT for colon and sigmoid cancers) are unavailable
  • Original preoperative, surgical and adjuvant treatment has not been documented or is unavailable

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Oslo University Hospital

Oslo, Norway, N-0424

Actively Recruiting

2

St Mark's Hospital

Harrow, London, United Kingdom

Actively Recruiting

3

Churchill Hospital

Oxford, Oxfordshire, United Kingdom

Actively Recruiting

4

Royal Marsden Hospital NHS Foundation Trust

Sutton, United Kingdom, SM2 5PT

Actively Recruiting

Loading map...

Research Team

C

Caroline Martin

CONTACT

S

Syvella Ellis

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here